Alvogen develops, manufactures, and sells generic, brand, over-the-counter brands, and biosimilar products for patients. Their molecules are for the treatment of conditions in the fields of oncology, cardiology, respiratory medicine, neurology, and gastroenterology. Their product formulations are manufactured and sold by oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments, and injectables.
Focus Areas
Notable Investments
